These terms and conditions govern your use of the website alphaminr.com and its related services.
These Terms and Conditions (“Terms”) are a binding contract between you and Alphaminr, (“Alphaminr”, “we”, “us” and “service”). You must agree to and accept the Terms. These Terms include the provisions in this document as well as those in the Privacy Policy. These terms may be modified at any time.
Your subscription will be on a month to month basis and automatically renew every month. You may terminate your subscription at any time through your account.
We will provide you with advance notice of any change in fees.
You represent that you are of legal age to form a binding contract. You are responsible for any
activity associated with your account. The account can be logged in at only one computer at a
time.
The Services are intended for your own individual use. You shall only use the Services in a
manner that complies with all laws. You may not use any automated software, spider or system to
scrape data from Alphaminr.
Alphaminr is not a financial advisor and does not provide financial advice of any kind. The service is provided “As is”. The materials and information accessible through the Service are solely for informational purposes. While we strive to provide good information and data, we make no guarantee or warranty as to its accuracy.
TO THE EXTENT PERMITTED BY APPLICABLE LAW, UNDER NO CIRCUMSTANCES SHALL ALPHAMINR BE LIABLE TO YOU FOR DAMAGES OF ANY KIND, INCLUDING DAMAGES FOR INVESTMENT LOSSES, LOSS OF DATA, OR ACCURACY OF DATA, OR FOR ANY AMOUNT, IN THE AGGREGATE, IN EXCESS OF THE GREATER OF (1) FIFTY DOLLARS OR (2) THE AMOUNTS PAID BY YOU TO ALPHAMINR IN THE SIX MONTH PERIOD PRECEDING THIS APPLICABLE CLAIM. SOME STATES DO NOT ALLOW THE EXCLUSION OR LIMITATION OF INCIDENTAL OR CONSEQUENTIAL OR CERTAIN OTHER DAMAGES, SO THE ABOVE LIMITATION AND EXCLUSIONS MAY NOT APPLY TO YOU.
If any provision of these Terms is found to be invalid under any applicable law, such provision shall not affect the validity or enforceability of the remaining provisions herein.
This privacy policy describes how we (“Alphaminr”) collect, use, share and protect your personal information when we provide our service (“Service”). This Privacy Policy explains how information is collected about you either directly or indirectly. By using our service, you acknowledge the terms of this Privacy Notice. If you do not agree to the terms of this Privacy Policy, please do not use our Service. You should contact us if you have questions about it. We may modify this Privacy Policy periodically.
When you register for our Service, we collect information from you such as your name, email address and credit card information.
Like many other websites we use “cookies”, which are small text files that are stored on your computer or other device that record your preferences and actions, including how you use the website. You can set your browser or device to refuse all cookies or to alert you when a cookie is being sent. If you delete your cookies, if you opt-out from cookies, some Services may not function properly. We collect information when you use our Service. This includes which pages you visit.
We use Google Analytics and we use Stripe for payment processing. We will not share the information we collect with third parties for promotional purposes. We may share personal information with law enforcement as required or permitted by law.
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
(1) |
Title of each class of securities to which transaction applies:
|
|
|
(2) |
Aggregate number of securities to which transaction applies:
|
|
|
(3) |
Per unit price or other underlying value of transaction computed pursuant to Exchange Act Rule 0-11 (set forth the amount on which the filing fee is calculated and state
how it was determined):
|
|
|
(4) |
Proposed maximum aggregate value of transaction:
|
|
|
(5) |
Total fee paid:
|
|
(1)
|
Amount Previously Paid:
|
|
|
(2)
|
Form, Schedule or Registration Statement No.:
|
|
|
(
3)
|
Filing Party:
|
|
|
(4)
|
Date Filed:
|
|
|
|
1. |
Elect a board of six directors to serve until the next annual meeting of shareholders, or until their successors have been duly elected and qualified;
|
|
|
2. |
Ratify the appointment of Plante & Moran PLLC as the Company’s independent registered public accounting firm for the 2019 fiscal year;
|
|
|
3. |
Approve, on an advisory basis, the compensation of the Company’s named executive officer; and
|
|
|
4. |
Transact such other business as may properly come before the meeting or any adjournment(s) or postponement(s) thereof.
|
|
BY ORDER OF THE BOARD OF DIRECTORS
|
|
|
/s/ Mark W. Harding
|
|
|
Mark W. Harding, President
|
|
|
|
· |
Election of Directors
– The election of directors requires the affirmative vote of
a plurality of the votes cast by shares represented in person or by proxy and entitled to vote for the election of directors. This means that the nominees receiving the most votes from those eligible to vote will be elected. You may
vote “FOR” all of the nominees or your vote may be “WITHHELD” with respect to one or more of the nominees; however, a “withheld” vote or a broker non-vote (defined above) will have no effect on the outcome of the election.
|
|
|
· |
Ratification of auditors, advisory vote on executive compensation, and other matters
– The number of votes cast in favor of the proposal at the Meeting must exceed the number of votes cast against the proposal for the approval of Proposals 2, 3 and other matters. For Proposals 2, 3 and any other business matters to be
voted on, you may vote “FOR,” “AGAINST,” or you may “ABSTAIN.” Abstentions and broker non-votes will not be counted as votes for or against a proposal and, therefore, have no effect on the vote. Because your vote on executive
compensation is advisory, it will not be binding on the board of directors or the Company. However, the board of directors will review the voting results and take them into consideration when making future decisions regarding executive
compensation.
|
|
Name and address of beneficial owner
|
Amount and nature
of beneficial ownership
|
Percent of class
|
|||||||
|
Mark W. Harding **
|
877,244
|
(1 | ) |
3.66
|
%
|
||||
|
Harrison H. Augur **
|
159,781
|
(2 | ) |
*
|
|||||
|
Patrick J. Beirne **
|
23,000
|
(3 | ) |
*
|
|||||
|
Arthur G. Epker, III
200 Clarendon Street, 48th Floor, Boston, MA 02116
|
51,500
|
(4 | ) |
*
|
|||||
|
Richard L. Guido **
|
51,500
|
(5 | ) |
*
|
|||||
|
Peter C. Howell **
|
52,000
|
(6 | ) |
*
|
|||||
|
All officers and directors as a group (6 persons)
|
1,215,025
|
(7 | ) |
5.03
|
%
|
||||
|
PAR Capital Management, Inc. / PAR Investment Partners, L.P. / PAR Group, L.P.
200 Clarendon Street, 48th Floor, Boston, MA 02116
|
5,982,970
|
(8 | ) | 25.15 | % | ||||
|
Trigran Investments, Inc.
630 Dundee Road, Suite 230, Northbrook, IL 60062
|
2,046,604
|
(9 | ) |
8.60
|
%
|
||||
| 1. |
Includes 150,001 shares purchasable by Mr. Harding under options exercisable within 60 days. Includes 210,000 shares of common stock held by SMA Investments, LLLP, a
limited liability limited partnership controlled by Mr. Harding.
|
| 2. |
Includes 49,000 shares purchasable by Mr. Augur under options exercisable within 60 days. Includes 10,000 shares of common stock held by Patience Partners, LLC, a limited
liability company in which a foundation controlled by Mr. Augur is a 60% member and Mr. Augur is a 20% managing member. Includes 46,111 shares of common stock held in a margin account owned by Auginco, a Colorado general partnership,
which is owned 50% by Mr. Augur and 50% by his wife.
|
| 3. |
Includes 23,000 shares purchasable by Mr. Beirne under options exercisable within 60 days.
|
| 4. |
Includes 49,000 shares purchasable by Mr. Epker under options exercisable within 60 days. Excludes all shares of common stock held directly by PAR Investment Partners, L.P.
(“PIP”). PAR Capital Management, Inc. (“PCM”), as the general partner of PAR Group, L.P. (“PGL”), which is the general partner of PIP, has investment discretion and voting control over shares held by PIP. No shareholder, director,
officer or employee of PCM has beneficial ownership (within the meaning of Rule 13d-3 promulgated under the Securities Exchange Act of 1934 (the “Exchange Act”)) of any shares held by PIP. Mr. Epker is an officer of PCM and has been a
director of the Company since 2007. In his capacity as an officer of PCM, Mr. Epker has sole voting and dispositive power with respect to the shares of common stock held by PIP; however, Mr. Epker disclaims beneficial ownership of the
shares held by PIP, except to the extent of his pecuniary interest, if any, therein by virtue of his equity ownership interest in PIP.
|
| 5. |
Includes 49,000 shares purchasable by Mr. Guido under options exercisable within 60 days.
|
| 6. |
Includes 49,000 shares purchasable by Mr. Howell under options exercisable within 60 days.
|
| 7. |
Includes the following shares:
|
|
|
a. |
210,000 shares held by SMA Investments, LLLP as described in number 1 above,
|
|
|
b. |
369,001 shares purchasable by directors and officers under options exercisable within 60 days, and
|
|
|
c. |
10,000 shares of common stock held by Patience Partners, LLC, and 46,111 shares of common stock held by Auginco, as described in number 2 above.
|
| 8. |
PIP owns directly 5,982,970 shares. PGL, through its control of PIP as general partner, has sole voting and dispositive power with respect to all 5,982,970 shares owned
beneficially by PIP. PCM, through its control of PGL as general partner, has sole voting and dispositive power with respect to all 5,982,970 shares owned beneficially by PIP. Excludes 2,500 shares owned by Mr. Epker and 49,000 shares
purchasable by Mr. Epker under options exercisable within 60 days. PIP, PGL and PCM disclaim beneficial ownership of the shares owned by Mr. Epker and the shares purchasable by Mr. Epker pursuant to options.
|
| 9. |
This disclosure is based on a Schedule 13G/A filed by Trigran Investments, Inc. (“TII”), Douglas Granat, Lawrence A. Oberman, Steven G. Simon, Bradley F. Simon and Steven
R. Monieson on February 14, 2018. It includes 2,046,604 shares of common stock owned by TII. By reason of their roles as controlling shareholders and/or sole directors of TII, each of Douglas Granat, Lawrence A. Oberman, Steven G.
Simon, Bradley F. Simon and Steven R. Monieson may be considered the beneficial owners of shares beneficially owned by TII.
|
|
Number of securities to be issued upon exercise of outstanding options
|
Weighted-average exercise price of outstanding options
|
Number of securities remaining available for future issuance under equity compensation plans (excluding securities reflected in
column (a))
|
|
|
Plan category
|
(a)
|
(b)
|
(c)
|
|
Equity compensation plans:
|
|||
|
Approved by security holders
|
535,500
|
$5.31
|
1,313,000
|
|
Not approved by security holders
|
—
|
—
|
—
|
|
Total
|
535,500
|
$5.31
|
1,313,000
|
|
Name
|
Age
|
Position
|
|
Harrison H. Augur
|
76
|
Chairman of the Board*
|
|
Patrick J. Beirne
|
55
|
Director*
|
|
Arthur G. Epker, III
|
56
|
Director*
|
|
Richard L. Guido
|
74
|
Director*
|
|
Mark W. Harding
|
55
|
Director, President, CEO and CFO*
|
|
Peter C. Howell
|
69
|
Director*
|
|
Fiscal 2018 Committee Membership
|
|||
|
Director
|
Audit Committee
|
Compensation
Committee
|
Nominating
Committee |
|
H. Augur
|
X
|
X
|
X
|
|
P. Beirne
|
—
|
—
|
—
|
|
A. Epker
|
—
|
Chair
|
X
|
|
R. Guido
|
X
|
X
|
Chair
|
|
M. Harding
|
—
|
—
|
—
|
|
P. Howell
|
Chair
|
—
|
—
|
|
|
· |
The full name, address, and telephone number of the person making the recommendation, and a statement that the person making the recommendation is a shareholder of record
(or, if the person is a beneficial owner of the Company’s shares but not a record holder, a statement from the record holder of the shares verifying the number of shares beneficially owned), and a statement as to whether the person
making the recommendation has a good faith intention to continue to hold those shares through the date of the Company’s next annual meeting of shareholders;
|
|
|
· |
The full name, address, and telephone number of the candidate being recommended, information regarding the candidate’s beneficial ownership of the Company’s equity
securities, any business or personal relationship between the candidate and the person making the recommendation, and an explanation of the value or benefit the person making the recommendation believes the candidate would provide as a
director;
|
|
|
· |
A statement signed by the candidate that he or she is aware of and consents to being recommended to the Nominating Committee and will provide such information as the
Nominating Committee may request for its evaluation of candidates;
|
|
|
· |
A description of the candidate’s current principal occupation, business or professional experience, previous employment history, educational background, and any areas of
particular expertise;
|
|
|
· |
Information about any business or personal relationships between the candidate and any of the Company’s customers, suppliers, vendors, competitors, directors or officers,
or other persons with any special interest regarding any transactions between the candidate and the Company; and
|
|
|
· |
Any information in addition to the above about the candidate that would be required to be included in the Company’s proxy statement (including without limitation
information about legal proceedings in which the candidate has been involved within the past ten years).
|
|
Director Compensation
|
||||||||||||
|
Name
|
Fees Earned
or Paid in
Cash
($)
|
Option
Awards (1)
($)
|
Total
($)
|
|||||||||
|
H. Augur (2)
|
23,500
|
30,548
|
54,048
|
|||||||||
|
P. Beirne (3)
|
14,500
|
30,548
|
45,048
|
|||||||||
|
A. Epker (4)
|
19,000
|
30,548
|
49,548
|
|||||||||
|
R. Guido (5)
|
25,000
|
30,548
|
55,548
|
|||||||||
|
P. Howell (6)
|
24,000
|
30,548
|
54,548
|
|||||||||
| (1) |
In addition to cash compensation, pursuant to the Pure Cycle Corporation 2014 Equity Incentive Plan effective as of April 12, 2014 (the “2014 Plan”), each non-employee
director may receive an option to purchase shares of common stock at the discretion of the board, and the terms of such awards granted to non-employee directors, including the discretion to adopt one or more formulas for the
determination of non-employee director awards, are at the discretion of the board. On January 14, 2015, the board adopted a formula under the 2014 Plan that provides for an option grant to each non-employee director to purchase 6,500
shares of common stock at each annual meeting of shareholders at which the non-employee director is re-elected to the board. The options vest on the date of the next annual meeting of shareholders or the first anniversary of the date of
grant, whichever is earlier. On January 27, 2016, the board adopted a formula under the 2014 Plan providing for an option grant to each non-employee director to purchase 10,000 shares of common stock upon initial election or appointment
to the board, which vests one-half on each of the first two anniversary dates of the grant. The option exercise price for all non-employee director grants is set at the fair market value of the common stock on the date of the grant. The
amounts in this column represent the aggregate grant date fair value of options granted during the Company’s fiscal year ended August 31, 2018, as computed in accordance with FASB ASC Topic 718. For more information about how the
Company values and accounts for share-based compensation see
Note 8 – Shareholders’ Equity
to the Company’s audited consolidated financial
statements for the year ended August 31, 2018, which are included in the Company’s 2018 Annual Report on Form 10-K.
|
| (2) |
The $23,500 earned by Mr. Augur is comprised of $12,000 for serving on the board, $1,000 for being chairman of the board, $3,000 for serving on three committees, and $7,500
for attendance at board and committee meetings ($500 per meeting prior to January 1, 2018 and $1,000 per meeting thereafter). Mr. Augur had options outstanding to purchase 49,000 shares of common stock as of August 31, 2018, all of
which are exercisable within 60 days of the filing of this proxy statement.
|
| (3) |
The $14,500 earned by Mr. Beirne is comprised of $12,000 for serving on the board and $2,500 for attendance at board meetings ($500 per meeting prior to January 1, 2018 and
$1,000 per meeting thereafter). Mr. Beirne had options outstanding to purchase 23,000 shares of common stock as of August 31, 2018, all of which are exercisable within 60 days of the filing of this proxy statement.
|
| (4) |
The $19,000 earned by Mr. Epker is comprised of $12,000 for serving on the board, $3,500 for serving as chairman of the Compensation Committee, $1,000 for serving on one
additional committee, and $2,500 for attendance at board and committee meetings ($500 per meeting prior to January 1, 2018 and $1,000 per meeting thereafter). Mr. Epker had options outstanding to purchase 49,000 shares of common stock
as of August 31, 2018, all of which are exercisable within 60 days of the filing of this proxy statement.
|
| (5) |
The $25,000 earned by Mr. Guido is comprised of $12,000 for serving on the board, $3,500 for serving as chairman of the Nominating Committee, $2,000 for serving on two
additional committees, and $7,500 for attendance at board and committee meetings ($500 per meeting prior to January 1, 2018 and $1,000 per meeting thereafter). Mr. Guido had options outstanding to purchase 49,000 shares of common stock
as of August 31, 2018, all of which are exercisable within 60 days of the filing of this proxy statement.
|
| (6) |
The $24,000 earned by Mr. Howell is comprised of $12,000 for serving on the board, $3,500 for serving as chairman of the Audit Committee, and $8,500 for attendance at board
and committee meetings ($500 per meeting prior to January 1, 2018 and $1,000 per meeting thereafter). Mr. Howell had options outstanding to purchase 49,000 shares of common stock as of August 31, 2018, all of which are exercisable
within 60 days of the filing of this proxy statement.
|
|
Summary Compensation Table
|
|||||||||||||||||
|
Name and Principal Position
|
Fiscal
Year
|
Salary
($)
|
Bonus
($)
|
Option
Awards
(1)
($)
|
Total
($)
|
||||||||||||
|
Mark W. Harding
|
2018
|
400,000
|
300,000
|
285,755
|
(2)
|
985,755
|
|||||||||||
|
President, CEO and CFO
|
2017
|
375,000
|
200,000
|
259,025
|
834,025
|
||||||||||||
|
|
(1) |
The amounts in this column represent the aggregate grant date fair value of stock options awarded in fiscal 2019 and 2018 (for performance in fiscal 2018 and 2017,
respectively) as computed in accordance with FASB ASC Topic 718. See
Note 8 – Shareholders’ Equity
to the Company’s audited consolidated
financial statements for the year ended August 31, 2018, which are included in our 2018 Annual Report on Form 10-K for a description of the assumptions used to value option awards and the manner in which the Company recognizes the
related expense pursuant to FASB ASC Topic 718.
|
|
|
(2) |
The option award was granted and approved on September 26, 2018, with an exercise price equal to $11.15, the closing market price of the Company’s common stock on the date
of grant. The option award vests in three equal installments on each of the first, second and third anniversary dates of the grant and will expire ten years from date of grant.
|
|
Outstanding Equity Awards at Fiscal Year-End
|
|||||||||||||
|
Name
|
Number of
Securities
Underlying
Unexercised
Options (#)
Exerciseable
|
Number of
Securities
Underlying
Unexercised
Options (#)
Unexerciseable
|
Option Exercise Price
|
Option
Expiration
Date
|
|||||||||
|
Mark W. Harding
|
100,000
|
0
|
$
|
5.88
|
8/14/2023
|
||||||||
|
Mark W. Harding
|
16,667
|
33,333
|
(1)
|
$
|
5.61
|
10/12/2026
|
|||||||
|
Mark W. Harding
|
0
|
50,000
|
(2)
|
$
|
7.60
|
9/27/2027
|
|||||||
|
(1)
|
One third of the total number of shares subject to the option vest on each of the first, second and third anniversary date of the grant date, October 12, 2016.
|
| (2) |
One third of the total number of shares subject to the option vest on each of the first, second and third anniversary date of the grant date, September 27, 2017.
|
|
For the Fiscal Years Ended
|
||||||||
|
August 31,
2018
|
August 31,
2017
|
|||||||
|
Audit Fees
(1)
|
$
|
105,000
|
$
|
127,000
|
||||
|
Audit-Related Fees
|
$
|
—
|
$
|
—
|
||||
|
Tax Fees
(2)
|
$
|
—
|
$
|
12,400
|
||||
|
All Other Fees
|
$
|
—
|
$
|
—
|
||||
|
Total
|
$
|
105,000
|
$
|
139,400
|
||||
| (1) |
Includes fees for the audit of the Company’s annual financial statements, the reviews of the Company’s quarterly financial statements and consents and other services
normally provided by the independent auditors in connection with statutory and regulatory filings or engagements for those fiscal years, regardless of when the fees were billed or services were rendered.
|
| (2) |
The tax fees consist entirely of fees for the preparation of the federal and state corporate tax returns.
|
No information found
* THE VALUE IS THE MARKET VALUE AS OF THE LAST DAY OF THE QUARTER FOR WHICH THE 13F WAS FILED.
| FUND | NUMBER OF SHARES | VALUE ($) | PUT OR CALL |
|---|
| DIRECTORS | AGE | BIO | OTHER DIRECTOR MEMBERSHIPS |
|---|
No information found
No Customers Found
No Suppliers Found
Price
Yield
| Owner | Position | Direct Shares | Indirect Shares |
|---|